Emergent BioSolutions (EBS) Free Cash Flow (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Free Cash Flow of -$36.2 million for Q1 2026, down 144.59% year-over-year from $81.2 million in Q1 2025, and down 146.47% quarter-over-quarter from $77.9 million in Q4 2025.
Emergent BioSolutions (EBS) Free Cash Flow (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$36.2 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 144.59% year-over-year to -$36.2 million; the TTM figure through Mar 2026 stood at $147.6 million (up 69.85% YoY), while the FY2025 annual figure was $169.0 million, up 372.07% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$36.2 million, down from $77.9 million in the prior quarter.
- The five-year high for Free Cash Flow was $175.6 million in Q4 2022, with the low at -$191.8 million in Q1 2023.
- The 5-year median for Free Cash Flow is -$14.8 million (2025), against an average of -$7.8 million.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow slumped 692.23% in 2024, then surged 195.47% in 2025.
- Emergent BioSolutions' Free Cash Flow stood at $175.6 million in 2022, then tumbled by 105.87% to -$10.3 million in 2023, then plunged by 692.23% to -$81.6 million in 2024, then soared by 195.47% to $77.9 million in 2025, then tumbled by 146.47% to -$36.2 million in 2026.
- Business Quant data shows EBS's Free Cash Flow at -$36.2 million in Q1 2026, $77.9 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | 54.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.00 Mn |
| Jun 30, 2026 | 54.00 Mn |
| Mar 31, 2026 | -36.20 Mn |
| Mar 31, 2026 | -36.20 Mn |
| Dec 31, 2025 | 77.90 Mn |
| Dec 31, 2025 | 77.90 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 103.50 Mn |
| Jun 30, 2025 | 103.50 Mn |
| Mar 31, 2025 | -14.80 Mn |
| Mar 31, 2025 | -14.80 Mn |
| Dec 31, 2024 | -81.60 Mn |
| Dec 31, 2024 | -81.60 Mn |
| Sep 30, 2024 | 147.90 Mn |
| Sep 30, 2024 | 147.90 Mn |
| Jun 30, 2024 | 35.40 Mn |
| Jun 30, 2024 | 35.40 Mn |
| Mar 31, 2024 | -65.90 Mn |
| Mar 31, 2024 | -65.90 Mn |